Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox

Trends in Immunology

Volumn 28, Issue 10, 2007, Pages 429-436

  Rubartelli, Anna ^a   Lotze, Michael T ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE; LIPOPOLYSACCHARIDE; NUCLEAR FACTOR; NUCLEAR PROTEIN; THIOL;

ADAPTIVE IMMUNITY; ARTICLE; AUTOIMMUNITY; CANCER; CELL DAMAGE; CHRONIC INFLAMMATION; CYTOPLASM; DISEASE ASSOCIATION; EXTRACELLULAR SPACE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MOLECULE; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATION REDUCTION STATE; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN FUNCTION; TISSUE INJURY; VIRUS INFECTION;

CYTOKINES; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; INFLAMMATION MEDIATORS; NEOPLASMS; OXIDATION-REDUCTION; PROTEINS;

EID: 34548857335     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2007.08.004     Document Type: Article

References (63)

1. Martinon F., and Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26 (2005) 447-454
2. Bianchi M.E. PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81 (2007) 1-5
3. Adib-Conquy M., and Cavaillon J.M. Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett. 581 (2007) 3723-3733
4. Scheibner K.A., et al. Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J. Immunol. 177 (2006) 1272-1281
5. Nickel W. The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 270 (2003) 2109-2119
6. Chimini G., and Rubartelli A. Novel pathways of protein secretion. In: Henderson B. (Ed). Molecular Chaperones and Cell Signalling (2005), Cambridge University Press, Cambridge 45-60
7. Scaffidi P., et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418 (2002) 191-195
8. Arner E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267 (2000) 6102-6109
9. Fernandes A.P., and Holmgren A. Glutaredoxins: glutathione dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid. Redox Signal. 6 (2004) 63-74
10. Pastore A., et al. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta 1 (2003) 19-39
11. Mansoor M.A., et al. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 200 (1992) 218-229
12. Ashfaq S., et al. The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J. Am. Coll. Cardiol. 47 (2006) 1005-1011
13. Ellgaard L. Catalysis of disulphide bond formation in the endoplasmic reticulum. Biochem. Soc. Trans. 32 (2004) 663-667
14. Ellgaard L., and Helenius A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell Biol. 4 (2003) 181-191
15. Leichert L.I., and Jakob U. Global methods to monitor the thiol-disulfide state of proteins in vivo. Antioxid. Redox Signal. 8 (2006) 763-772
16. Muesch A., et al. A novel pathway for secretory proteins?. Trends Biochem. Sci. 15 (1990) 86-88
17. Rubartelli A., et al. A novel secretory pathway for interleukin-1β, a protein lacking a signal sequence. EMBO J. 9 (1990) 1503-1510
18. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
19. Gardella S., et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3 (2002) 995-1001
20. Semino C., et al. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106 (2005) 609-616
21. Rubartelli A., et al. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J. Biol. Chem. 267 (1992) 24161-24164
22. Wakasugi N., et al. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 8282-8286
23. Angelini G., et al. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 1491-1496
24. Nguyen M.T., et al. A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions. J. Biol. Chem. 278 (2003) 33654-33671
25. Kamogashira T. Site-specific mutagenesis of the human interleukin-1 β gene: structure-function analysis of the cysteine residues. Biochem. Biophys. Res. Commun. 150 (1988) 1106-1114
26. Yamamoto Y., et al. Generation of highly stable IL-18 based on a ligand-receptor complex structure. Biochem. Biophys. Res. Commun. 317 (2004) 181-186
27. Camby I., et al. Galectin-1: a small protein with major functions. Glycobiology 16 (2006) 137R-157R
28. Inagaki Y., et al. Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties. Eur. J. Biochem. 267 (2000) 2955-2964
29. Koppal T., et al. S100B proteins that lack one or both cysteine residues can induce inflammatory responses in astrocytes and microglia. Neurochem. Int. 39 (2001) 401-407
30. Gardella S., et al. CD8(+) T lymphocytes induce polarized exocytosis of secretory lysosomes by dendritic cells with release of interleukin-1β and cathepsin D. Blood 98 (2001) 2152-2159
31. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
32. Panayi G.S., et al. Stress cytokines: pivotal proteins in immune regulatory networks. Curr. Opin. Immunol. 16 (2004) 531-534
33. Boeynaems J.M., and Communi D. Modulation of inflammation by extracellular mucleotides. J. Invest. Dermatol. 126 (2006) 943-944
34. Bours M.J., et al. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112 (2006) 358-404
35. Shi Y., et al. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425 (2003) 516-521
36. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
37. Sato S., and Nieminen J. Seeing strangers of announcing "danger": galectin-3 in two models of innate immunity. Glycoconj. J. 19 (2004) 583-591
38. Mosley B., et al. The interleukin-1 receptor binds the human interleukin-1α precursor but not the interleukin-1β. J. Biol. Chem. 262 (1987) 2941-2944
39. Lotfi R., et al. Eosinophilic granulocytes and damage associated molecular pattern molecules (DAMPs). J. Immunother. 30 (2007) 16-28
40. Lu L.F., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 997-1002
41. Kitawaki T., et al. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. Int. Immunol. 18 (2006) 1789-1799
42. de Visser K.E., et al. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6 (2006) 24-37
43. Sakurai T., et al. Loss of hepatic NF-κB activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10544-10551
44. Karin M., et al. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124 (2006) 823-835
45. Karin M. Nuclear factor-κB in cancer development and progression. Nature 441 (2006) 431-436
46. Degenhardt K., and White E. A mouse model system to genetically dissect the molecular mechanisms regulating tumorigenesis. Clin. Cancer Res. 12 (2006) 5298-5304
47. Jin S., and White E. Role of autophagy in cancer: management of metabolic stress. Autophagy 3 (2007) 93-95
48. Degenhardt K., et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10 (2006) 51-64
49. Vakkila J., and Lotze M.T. Inflammation and necrosis promote tumour growth. Nat. Rev. Immunol. 4 (2004) 641-648
50. Lotze M.T., and DeMarco R.A. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr. Opin. Investig. Drugs 4 (2003) 1405-1409
51. Pardo O.E., et al. FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCε. EMBO J. 25 (2006) 3078-3088
52. Diederichs S., et al. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Res. 64 (2004) 5564-5569
53. Zou M., et al. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br. J. Cancer 93 (2005) 1277-1284
54. Powis G., et al. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29 (2000) 312-322
55. Mitchell R.A. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell. Signal. 16 (2004) 13-19
56. Pouyssegur J., et al. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
57. Hedley D., et al. Up-regulation of the redox mediators thioredoxin and apurinic/apyrimidinic excision (APE)/Ref-1 in hypoxic microregions of invasive cervical carcinomas, mapped using multispectral, wide-field fluorescence image analysis. Am. J. Pathol. 164 (2004) 557-565
58. Csiki I., et al. Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1 in non-small cell lung cancer. Cancer Res. 66 (2006) 143-150
59. Bacher M., et al. Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am. J. Pathol. 162 (2003) 11-17
60. Goplen D., et al. Protein disulfide isomerase expression is related to the invasive properties of malignant glioma. Cancer Res. 66 (2006) 9895-9902
61. Vukovic V., et al. Microregional heterogeneity of non-protein thiols in cervical carcinomas assessed by combined use of HPLC and fluorescence image analysis. Clin. Cancer Res. 6 (2000) 1826-1832
62. Moreno-Merlo F., et al. Association between tissue hypoxia and elevated non-protein sulphydryl concentrations in human cervical carcinoma xenografts. Br. J. Cancer 81 (1999) 989-993
63. Jordan P.A., and Gibbins J.M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signal. 8 (2006) 312-324